SCHEMBL21352247

SCHEMBL21352247

CC(c1ccc(C(=O)c2ccc(F)cc2)c(Br)c1)S(=O)(=O)C(C)C(C)(C)NC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
TP53 P04637 1/20 0.36
KMT2A Q03164 1/20 0.36
EPHX2 P34913 4/20 0.33
CNR2 P34972 3/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
PTGS2 P35354 1/20 0.32
RXRA P19793 1/20 0.32
NPC1 O15118 1/20 0.32
BDKRB1 P46663 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 2/20 0.31
USP2 O75604 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ALPG P10696 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21352127 0.83 KMT2A (0.39) LMNAMAPTHTTTP53KMT2A
SCHEMBL21352080 0.79 MAPK14 (0.33) LMNAMAPTHTTTP53KMT2A
SCHEMBL21351899 0.75 CNR2 (0.35) LMNAKMT2AEPHX2CNR2ALDH1A1
SCHEMBL21352249 0.75 BACE1 (0.34) LMNAHTTKMT2AEPHX2CNR2
SCHEMBL20157564 0.73 LMNA (0.42) LMNAHTTKMT2AALDH1A1SMN1; SMN2
SCHEMBL20157556 0.73 LMNA (0.44) LMNAMAPTHTTTP53KMT2A
SCHEMBL21351900 0.73 CNR2 (0.35) LMNAKMT2ACNR2ALDH1A1SMN1; SMN2
SCHEMBL21352025 0.71 KDM4E (0.36) LMNAMAPTHTTTP53KMT2A
SCHEMBL20158052 0.70 LMNA (0.39) LMNAHTTKMT2AALDH1A1SMN1; SMN2
SCHEMBL21351930 0.69 LMNA (0.39) LMNAMAPTHTTTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed